The association of Daunorubicin and Steven-Johnson Syndrome (SJS) has not been well-established. In this report, we describe a fatal case of a 2 years old boy with acute leukemia who developed Steven-Johnson Syndrome owing to Daunorubicin. Clinicians should consider the possible association of Daunorubicin with SJS.